<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01732120</url>
  </required_header>
  <id_info>
    <org_study_id>myIRB ID 201208091</org_study_id>
    <nct_id>NCT01732120</nct_id>
  </id_info>
  <brief_title>Off Clamp Randomization</brief_title>
  <official_title>Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Midwest Stone Institute.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to compare the effects on kidney function after&#xD;
      performing the removal of a kidney tumor with or without clamping the blood vessels during&#xD;
      surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">May 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Renal function</measure>
    <time_frame>3 months post nephrectomy</time_frame>
    <description>Renal function following nephrectomy with and without clamping will be assessed using:&#xD;
decline in estimated glomerular filtration rate&#xD;
decline in split renal function</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oncologic outcomes</measure>
    <time_frame>3 years</time_frame>
    <description>Oncologic outcomes will be assessed based on:&#xD;
pathological results&#xD;
evidence of disease recurrence or metastasis on follow-up imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative outcomes</measure>
    <time_frame>3 months</time_frame>
    <description>Perioperative outcomes will be assessed based on:&#xD;
estimated blood loss&#xD;
operative time and warm ischemia time&#xD;
intra-operative complications&#xD;
length of postoperative hospital stay&#xD;
postoperative complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Renal Cancer</condition>
  <condition>Renal Ischemia</condition>
  <arm_group>
    <arm_group_label>Off-clamp partial nephrectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Partial nephrectomy will be performed without clamping of the renal blood vessels.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional partial nephrectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Partial nephrectomy will be performed with clamping of the renal blood vessels.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Off-clamp partial nephrectomy</intervention_name>
    <arm_group_label>Off-clamp partial nephrectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients 18 and older.&#xD;
&#xD;
          -  Patients willing and able to sign consent.&#xD;
&#xD;
          -  Patients with an organ confined renal mass planning to undergo a robotic assisted&#xD;
             partial nephrectomy (RAPN).&#xD;
&#xD;
          -  Patient with Karnofsky Performance Status (KPS) equal to or greater than 40.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18.&#xD;
&#xD;
          -  Patients with Karnofsky Performance Status (KPS) less than 40.&#xD;
&#xD;
          -  Patients with non-organ confined renal masses (invading renal vein, inferior vena&#xD;
             cava, peri-renal tissue, ipsilateral adrenal gland, or metastasis).&#xD;
&#xD;
          -  Patients with bilateral synchronous renal masses.&#xD;
&#xD;
          -  Patients who can not discontinue Plavix, Coumadin or other anti-platelet or&#xD;
             anti-coagulant medications.&#xD;
&#xD;
          -  Patients with renal lesions determined to be too complex to perform a RAPN without&#xD;
             clamp by the surgeon. (The renal mass may be deemed too difficult based on&#xD;
             pre-operatively radiological findings. The surgeon's decision to exclude a mass from a&#xD;
             robotic assisted partial nephrectomy would be based on a higher risk of positive&#xD;
             margin or complication if a RAPN was performed.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert S Figenshau, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 16, 2012</study_first_submitted>
  <study_first_submitted_qc>November 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2012</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>off-clamp</keyword>
  <keyword>partial nephrectomy</keyword>
  <keyword>renal cancer treatment</keyword>
  <keyword>renal ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

